Participants 14 93 5
irresectable hepatocellular carcinoma with repeated transient dearterialization
Participants 179 400 6
40 patients with the irresectable hepatocellular carcinoma (HCC) admitted to the department of HPB surgery in the First Affiliated Hospital of SUMS were randomized into two groups: (20 each) from Feb. 1994 to April, 1995.
